secwatch / observer
8-K filed May 12, 2025, 7:59 PM ET CIK 0000727207
regulatory confidence high sentiment negative materiality 1.00

Accelerate Diagnostics, Inc: Nasdaq/NYSE listing notice — Accelerate Diagnostics to be delisted from Nasdaq after Chapter 11 filing; shares to trade OTC under AXDXQ

Accelerate Diagnostics, Inc

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Accelerate Diagnostics, Inc received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1, 5550(a)(2), 5550(b)(2)).

Exchange
nasdaq
Notice
delisting notice
Rules
5101, 5110(b), IM-5101-1, 5550(a)(2), 5550(b)(2)
Exact text from the filing
”). On May 8, 2025, the Company received written notice (the “ Delisting Notice ”) from the Listing Qualifications Staff (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, as a result of the Bankruptcy Petitions and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the Staff has determined that the Company’s common stock (the “ Securities ”) will be delisted from Nasdaq. In addition, on May 6, 2025, the Company received written notice from the Staff notifying the Company that, for the last 30 consecutive business days, the closing bid pr
View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001104659-25-047314
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.